4.300
+4,88%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +569.3% | +242.4% | 2 / 3 | -12.7% | +20.89 pp | +21.79 pp | +17.5% | 0.08 | 1.61 | 36,6 | −12,7% | 6,7 | +550,7% | 1.61 | 47.57 | −96,6% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 4.300 (close price on 2026-10-19)EPS (TTM): 2.668
Financial charts
1.Revenue & growth
VND bn36,6Q2/26
1.Revenue & growth
VND bn36,6Q2/26
2.Profit & growth
VND bn6,69Q2/26
3.Profit mix (Penman)
VND bn292Q2/26
4.Margins & cost structure
%5.1%Q2/26
5.Returns & cash cycle
% · days23.1%Q2/26
6.Earnings quality & cash
VND bn-5.010Q2/26
7.Asset structure
VND bn2.287Q2/26
8.Funding & debt health
VND bn · times2.287Q2/26
9.Revenue backlog
VND bn58,3Q2/26
10.Valuation
times · %2,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %67Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
79.0%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26